Abstract
Abstract:Background: It is now becoming increasingly recognized that the effects of vitamin D supplementation may vary by several factors including vitamin D deficiency status, ethnicity, and/or the presence of genetic variants, which affect individual responses to supplementation. This study investigates the interaction between metabolic traits and circulating 25-hydroxyvitamin-D (25OHD) concentration with 4 polymorphisms of vitamin D receptor (VDR) including BsmI, ApaI, TaqI, FokI, and vitamin D supplementation. Methods: A systematic review and meta-analysis of papers until August 2021 on PubMed, The Cochrane Library, Scopus, Web of Science, Google Scholar, ProQuest, Science Direct, and Embase about the association between functionally relevant VDR variants and vitamin D supplementation on circulating 25OHD and metabolic traits. Results: A total of 2994 cases from 16 randomized controlled trial (RCT) studies were included in meta-analyses. There were no significant changes in the serum concentrations of 25OHD and metabolic traits after vitamin D supplementation in different variants of BsmI, ApaI, TaqI, and FokI polymorphism in the VDR gene in the overall analysis (p>0.05). However, the results showed there is significant interaction between these above VDR polymorphisms and vitamin D supplement on serum 25OHD level after subgroup analyses based on the study duration, gender, age, BMI, health status, Hardy–Weinberg Equilibrium, PCR, and race (p<0.05). Conclusions: The present meta-analysis demonstrates that the effect of vitamin D supplementation on serum 25OHD and metabolic traits is independent of genetic variants of the VDR gene (BsmI, ApaI, TaqI, and FokI). However, future trials should consider inter-individual differences and, in particular, should aim to clarify whether certain subgroups of individuals may benefit from vitamin D supplementation in the context of metabolic health.
References
1 . Targeted 25-hydroxyvitamin D concentration measurements and vitamin D 3 supplementation can have important patient and public health benefits. Eur J Clin Nutr. 2020;74(3):366–76.
2 Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;74(11):1498–513.
3 . Function of the vitamin D endocrine system in mammary gland and breast cancer. Mol Cell Endocrinol. 2017;453:88–95.
4 . Vitamin D and breast cancer: Past and present. J Steroid Biochem. 2018;177:15–20.
5 . Genetic factors and molecular mechanisms of vitamin D and obesity relationship. Ann Nutr Metab. 2018;73:89–99.
6 Vitamin D receptor gene polymorphisms modify cardiometabolic response to vitamin D supplementation in T2DM patients. Sci Rep. 2017;7(1):1–10.
7 . Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clin Immunol. 2009;133(2):276–81.
8 Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes. 2002;51(7):2294–300.
9 Vitamin D Receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care. 2013;36(3):550–6.
10 . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.
11 The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343.
12 P value-driven methods were underpowered to detect publication bias: analysis of Cochrane review meta-analyses. J Clin Epidemiol. 2020;118:86–92.
13 Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls. Bone. 2009;45(6):1091–7.
14 Vitamin D receptor gene polymorphisms affecting changes in visceral fat, waist circumference and lipid profile in breast cancer survivors supplemented with vitamin D3. Lipids Health Dis. 2019;18(1):1–10.
15 Vitamin D receptor genetic variation and cancer biomarkers among breast cancer patients supplemented with vitamin D3: a single-arm non-randomized before and after trial. Nutrients. 2019;11(6):1264.
16 . Circulating 25-hydroxy vitamin D relative to vitamin D receptor polymorphism after vitamin D3 supplementation in breast cancer women: A randomized, double-blind controlled clinical trial. Asian Pac J Cancer Prev. 2017;18(7):1953.
17 . Vitamin D receptor (BsmI) genotypes influence inflammatory and oxidative stress responses to altered vitamin D intake in subjects with Type 2 diabetes: A randomized controlled trial. JNSD. 2015;116–26.
18 . Genetic variations in VDR could modulate the efficacy of vitamin D3 supplementation on inflammatory markers and total antioxidant capacity among breast cancer women: a randomized double blind controlled trial. Asian Pac J Cancer Prev. 2019;20(7):2065.
19 Effects of genetic and nongenetic factors on total and bioavailable 25 (OH) D responses to vitamin D supplementation. J Clin Endocrinol Metab. 2017;102(1):100–10.
20 . Influence of vitamin D receptor gene Fok1 polymorphism on bone mass accrual post calcium and vitamin D supplementation. Indian J Pediatr. 2015;82(11):985–90.
21 . The association between polymorphisms of vitamin d metabolic-related genes and vitamin D3 supplementation in type 2 diabetic patients. J Diabetes Res. 2019;2019.
22 Effect of vitamin D receptor polymorphisms on plasma oxidative stress and apoptotic biomarkers among breast cancer survivors supplemented vitamin D3. Eur J Cancer Prev. 2020;29(5):433–44.
23 Association between bat vitamin D receptor 3’ haplotypes and vitamin D levels at baseline and a lower response after increased vitamin D supplementation and exposure to sunlight. Int J Vitam Nutr Res. 2019;90(3–4):1–5.
24 . The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res. 1997;12(8):1241–5.
25 , Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers. Exp Gerontol. 2015;66:10–6.
26 Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J Clin Endocrinol Metab. 2014;99(10):E2133–E7.
27 Vitamin D receptor gene polymorphisms and cardio-metabolic profile in women with hypovitaminosis D. JNSD. 2016;2(2):40–7.
28 Vitamin D receptor gene polymorphisms and HLA DRB1*04 cosegregation in Saudi type 2 diabetes patients. J Immunol. 2012;188(3):1325–32.
29 Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.
30 Vitamin D receptor gene polymorphisms modify the association of serum 25-hydroxyvitamin D levels with handgrip strength in the elderly in Northern China. Nutrition. 2019;57:202–7.
31 Relationship between cardiometabolic profile, vitamin D status and BsmI polymorphism of the VDR gene in non-institutionalized elderly subjects: Cardiometabolic profile, vitamin D status and BsmI polymorphism of the VDR gene in non-institutionalized elderly subjects. Exp Gerontol. 2016;81:56–64.
32 C-reactive protein levels and vitamin d receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients. Mol Diagn Ther. 2012;16(2):115–24.
33 . Relationship between Vitamin D Receptor gene polymorphisms and the components of metabolic syndrome. Nutr J. 2013;12(1):1–7.
34 . Regulation of adiposity by dietary calcium. FASEB J. 2000;14(9):1132–8.